title: Situation of drug resistant tuberculosis in Saharia tribe of central India.
abstract: OBJECTIVE
  The information on multidrug resistant tuberculosis (MDR-TB) situation amongst Saharia, one of the Particularly Vulnerable Tribal Groups (PVTGs) in Madhya Pradesh, India, is not available. Hence, this study was undertaken to find the situation of MDR-TB amongst Saharia PVTG in two districts of Madhya Pradesh.
  
  
  METHODS
  Community based cross-sectional TB prevalence surveys were conducted among Saharia PVTG in Gwalior and Shivpuri districts of Madhya Pradesh. Chest symptomatics were identified from the individual registered for the study. Two sputum samples were collected from each of the eligible individuals, transported to the laboratory, and were examined by Ziehl-Neelsen (Z-N) smear microscopy and solid medium culture methods. Drug susceptibility testing of the isolates was done by indirect proportion method on solid medium.
  
  
  RESULTS
  MDR rate was 2.2 per cent of new cases and 8.2 per cent among the previously treated cases of TB in Gwalior while it was two per cent among the previously treated cases in Shivpuri district.
  
  
  CONCLUSIONS
  Though the prevalence of tuberculosis in these districts was alarmingly high, the MDR rates were more or less similar to national average. However, the findings of this study highlight the need for active intervention so that the MDR-TB is kept under control.
authors.affiliation: National Institute for Research in Tribal Health (ICMR), Jabalpur, Madhya Pradesh, India.
authors.forename: J
authors.initials: J
authors.lastname: Bhat
authors.forename: V G
authors.initials: VG
authors.lastname: Rao
authors.forename: R
authors.initials: R
authors.lastname: Yadav
authors.forename: M
authors.initials: M
authors.lastname: Muniyandi
authors.forename: R
authors.initials: R
authors.lastname: Sharma
authors.forename: C
authors.initials: C
authors.lastname: Karfarma
authors.forename: C
authors.initials: C
authors.lastname: Luke
mesh_terms: D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007194:India; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity; D044382:Population Groups; D015995:Prevalence; D013183:Sputum / Q000382:microbiology; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents